Josep Carreras Leukaemia Research Institute
CatalàCA
Scientific Founding Members
Management commission
Internal Scientific Committee
Coordinators of the 3 Campuses
Research Directors on the Campuses
Why a Research Institute focusing on Leukaemia & other malignant blood diseases?
IJC Campus Clinic-UB
Campus ICO-Germans Trias i Pujol
Campus Sant Pau
Josep Carreras International Leukaemia Foundation
Cancer and Leukemia Epigenetics and Biology Program PEBCL
Cancer epigenetics
Chromatin biology laboratory
Chromatin, metabolism and cell fate
3D chromatin organization
Epigenetics and immune disease
Lymphocyte development and disease
Regulatory genomics
Regulatory RNA and chromatin
Epigenetic control of haematopoiesis
Transcriptional dynamics in leukemia
Cancer Immunogenomics
Cancer Heterogeneity and Hierarchies
Leukemia and Immuno-Oncology
Cellular Systems Genomics
Experimental and Clinical Hematology Program PHEC
Barcelona Endothelium Team (BET)
Functional cytomics
Myeloid neoplasms
Immunohematology and glycobiology
Leukemia stem cell group
Lymphoid neoplasms
Stem cell biology, developmental leukemia and immunotherapy
Stem cell transplantation and cellular Immunotherapy
Epigenetic Therapies
Lymphoma Translational Group
Oncogenesis and Antitumor Drugs
Microarrays Unit (UM)
Cytogenetics Platform
IJC Sample Collection for Leukemia and other Hematological Diseases
Proteomics Unit
Genomics Unit
Bioinformatics Unit
POSTDOCTORAL / EXPERIENCED RESEARCHER MSCA FELLOWSHIP IN LYMPHOCYTE DEVELOPMENT AND DISEASE
MSCA_MP2020
Deadline for application
Applicants must have a compelling track record appropriate to their career stage of peer-reviewed publication(s) in internationally recognized outlets, conference invitations or other indicators of success and must meet the Scheme's eligibility requirements, outlined below:
- Be in the possession of a doctoral degree or have at least four years of full-time equivalent research experience at the time of the call deadline.
- Comply with the mobility rule: you cannot apply for a fellowship in our institution if you do not meet the call mobility rule -> might change depending on the type of MSCA IF.
The MSCA-IF grant provides living allowance covering one to two years' salary, a mobility allowance, as well as research, training and networking costs, which translates in a very competitive salary conditions to the average cost of living in Barcelona, which is a dynamic, vibrant and multi-cultural European capital city.
For more information about the financial aspects, you can check the Guide for applicants.
Please note, that a labour contract with IJC includes automatically your registration in the Spanish Social Security System, covering you in term of medical assistance. Consequently, you will pay social security contributions and Personal taxes, deducted directly from the gross salary. For more information, please visit Tax Agency.
We welcome applications from outstanding researchers eager to study Lymphocyte Development and Disease, at Research Group of Dra. Maribel Parra for the Marie Sklodowska-Curie Actions Individual Fellowships Call.
The Lymphocyte Development and Disease group is devoted to understand the transcriptional and epigenetic mechanisms involved in the correct generation of B lymphocytes and how their deregulation may lead to the development of hematological diseases such as leukemia and lymphoma.
Please also visit our group webpage:
https://www.carrerasresearch.org/en/lymphocyte-development-and-disease_124537
More information can be obtained by consulting the MSCA-IF call page in the Funding and Tenders Portal and the Horizon 2020 Work Programme 2018-2020 / Section 3. Marie Skłodowska-Curie actions.
NOTE: Exceptional situations or career breaks can be taken in consideration, if a justification is provided.
Our mission is to carry out research into the basic, epidemiological, preventive, clinical and translational aspects of leukemia and other hematologic malignancies.
The vision of the Josep Carreras Leukaemia Research Institute is that research will identify new therapeutic targets and enable us to develop more precise and less aggressive treatments. We aspire to understand the origin and development of leukemias and other malignant haematological pathologies in order to be able to prevent them. We will work for a future in which all leukemias will be curable.
For further information, please, visit our webpage: http://www.carrerasresearch.org/en and the Josep Carreras non-profit organization: https://www.fcarreras.org/en
The Josep Carreras Institute is member of the Research Centers of Excellence of Catalonia (CERCA, Catalan Government), also accredited by the Spanish Ministry of Health as Health Research Centre of Excellence (ISCIII) and by the Spanish Association Against Cancer (Asociación Española contra el Cáncer, AEEC). The institute also holds the HR Excellence in Research recognition awarded by the European Commission.
The European Commission awarded the IJC the HR Excellence seal in July 2019. The IJC continues to work to maintain its policies in line with the Charter and Code principles.
The HRS4R has the main objective of ensuring that research centers of excellence implement and respect the requirements of the European Charter for Researchers and the Code of Conduct for hiring researchers (from here on referred to as the Charter and Code) within their human resources policies.
This EC initiative aims to promote training, professional development, and mobility for all European scientists. The IJC supports these values and principles, which will not only serve to strengthen its internal policies but will actively stimulate excellent research and firmly situate the organization as an institution with a stimulating working environment that favours the development of its scientists.
IJC is an equal opportunity employer. We evaluate qualified applicants without regard to race, colour, religion, sex, national origin, disability, and other legally protected characteristics.
Place of presentation of the candidacies
If you are ready to take the next step in your research career send your expression of interest and if the Scientific Supervisor accepts your candidature, you will jointly submit an Individual Fellowship proposal to the open European Commission call. Therefore, you must be available to work in the MSCA-IF proposal application between June and the first week of September 2020, considering that the call deadline is 09/09/2020.
Candidates must send an updated two-page CV with the contact details of 2 referees, a motivation letter and a one-page research project outline to jobs@carrerasresearch.org indicating in the subject of the message: MSCA_MP2020 candidate.
Deadline for Applications
Deadline expression of interest: may 25th 2020
The candidates will be informed of the pre-selection results no more than two weeks after the expression of interest deadline.
Deadline MSCA-IF call: September 9th 2020
Decisions will be announced in February 2021, after which the selected candidates can start their fellowship. An attractive feature of MSCA-IF is the flexibility of the European Commission (EC) in fixing the start date of funded projects. If necessary, this date could be delayed up to 18 months after the signing of the Grant Agreement. In the current call (2019), it would mean that projects could delay until mid-2021. The fellows be able to optimize the end date of other research contracts through this possibility.
MSCA FELLOWSHIP IN LYMPHOCYTE DEVELOPMENT AND DISEASE(PDF 580KB)
Josep Carreras Leukaemia Research Institute (IJC)
Ctra de Can Ruti, Camí de les Escoles, s/n
The IJC is a CERCA center.
List of Contacts